Barely Significant
← all excerpts

GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.

Int J Mol Sci · 2024 · PMC10855649 · PMID 38338686

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Lung metastases were identified in all mice, however, the metastatic load in lung, evaluated via bioluminescence imaging, showed a trend towards a dose-dependent reduction upon treatment, although not reaching statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.